# Protogabio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/protogabio

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.protogabio.com
- Total disclosed funding: $14M
- Latest round: Series A (Aug 16, 2023)
- Investors on record: 3

## About

Established in 2021 and based in Beijing, China, Protogabio is a biotechnology company that focuses on providing microalgae commercialization CDMO (Contract Development and Manufacturing). The company's CEO and founder, Yibo Xiao, has a Ph.D. in biology from Tsinghua University and also serves as director of the Microalgae Biosynthesis R&D Center at Tsinghua University Research Institute in Shenzhen. It has partnerships with nest.bio, Deeptech, ifiber, and Northeastern Agricultural University. In August 2023, it raised approximately CNY 100 million in series A funding.

The company's main business is to develop microalgae synthetics and provide microalgae commercialization CDMO services. Its self-developed products include microalgae biosynthesis platforms and modular flexible production platforms. Its products are used in the field of medicine and health care, skin health, agricultural farming, food nutrition.

## Funding rounds

- Series A, Aug 16, 2023, $14M — Hengxu Capital, Sanya Yazhouwan Venture Capital, Houshi Investment

## Investors

- Hengxu Capital (https://capitalatlas.ai/funds/hengxu-capital) — Series A
- Sanya Yazhouwan Venture Capital — Series A
- Houshi Investment — Series A